Disclosures
Raymond P. Roos, MD, FAAN
| Scientific Advisory Boards | |
| Scientific Advisory Board/DSMB - Mallinckrodt clinical trial with ACTH in ALS - Sarepta - Revalesio | |
| Editorial Boards | |
| Virology, Editorial Board Neurology Genetics, Associate Editor MedLink, Editor-in-Chief | |
| Consultancies | |
| Best Doctors American Institute of Biological Sciences Biohaven Pharmaceutical Holding Company Limited Gerson Lehrman Group Guidepoint Global Pinnacle Research Group Stealth Biotherapeutics | |
| Research Support, Commercial Entities | |
| Mallinckrodt Ravelesio Ionis Pharmaceuticals | |
| Research Support, Government Entities | |
| NINDS, NIH, 1 R21 NS078142-01 (PI) 3/15/12-1/31/15 | |
| Research Support, Foundations and Societies | |
| (i) ALS Association (ii) Chicago Biomedical Consortium (iii) Lohengrin Foundation | |
| Stock/Stock Options, Research Sponsor | |
| Ionis iv) | |
| Stock/Stock Options, Medical Equipment & Materials | |
| Ionis Merck Amgen IBM Apple Cigna Express Scripts General Electric | |